Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
63.488,19
1,31%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ F star Therapeutics Inc (FSTX) F star Therapeutics Inc (FSTX) Notizie

FSTX

F star Therapeutics (FSTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FSTX
DataOraFonteTitoloSimboloCompagnia
17/03/202321:24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FSTXF star Therapeutics Inc
14/03/202311:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FSTXF star Therapeutics Inc
09/03/202315:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FSTXF star Therapeutics Inc
09/03/202314:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FSTXF star Therapeutics Inc
09/03/202314:38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FSTXF star Therapeutics Inc
09/03/202314:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FSTXF star Therapeutics Inc
09/03/202314:22Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FSTXF star Therapeutics Inc
09/03/202314:08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FSTXF star Therapeutics Inc
07/03/202315:19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FSTXF star Therapeutics Inc
14/02/202322:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FSTXF star Therapeutics Inc
10/11/202222:37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FSTXF star Therapeutics Inc
09/09/202222:22Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:FSTXF star Therapeutics Inc
09/09/202222:16Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FSTXF star Therapeutics Inc
15/07/202212:16TipRanksH.C. Wainwright Sticks to Its Hold Rating for F-star Therapeutics (FSTX)NASDAQ:FSTXF star Therapeutics Inc
07/07/202217:40Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:FSTXF star Therapeutics Inc
07/07/202212:05Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:FSTXF star Therapeutics Inc
24/06/202215:52TipRanksSino Biopharmaceutical to Acquire F-star Therapeutics SharesNASDAQ:FSTXF star Therapeutics Inc
23/06/202222:59Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:FSTXF star Therapeutics Inc
23/06/202221:39Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:FSTXF star Therapeutics Inc
17/05/202212:15TipRanksH.C. Wainwright Thinks F-star Therapeutics’ Stock is Going to RecoverNASDAQ:FSTXF star Therapeutics Inc
12/05/202209:35TipRanksF-star Therapeutics (FSTX) Receives a Buy from SVB SecuritiesNASDAQ:FSTXF star Therapeutics Inc
02/05/202217:15TipRanksLeerink Partners Thinks F-star Therapeutics’ Stock is Going to RecoverNASDAQ:FSTXF star Therapeutics Inc
27/04/202222:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FSTXF star Therapeutics Inc
22/04/202222:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FSTXF star Therapeutics Inc
15/03/202212:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FSTXF star Therapeutics Inc
02/03/202200:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FSTXF star Therapeutics Inc
20/01/202214:00GlobeNewswire Inc.F-star Announces Issuance of U.S. Patent Protecting FS118, a Bispecific Antibody Targeting PD-L1 and LAG-3NASDAQ:FSTXF star Therapeutics Inc
07/01/202214:00GlobeNewswire Inc.F-star Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:FSTXF star Therapeutics Inc
05/01/202214:00GlobeNewswire Inc.F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology CollaborationNASDAQ:FSTXF star Therapeutics Inc
07/12/202115:05GlobeNewswire Inc.F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO Immuno-Oncology Congress 2021NASDAQ:FSTXF star Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FSTX

La tua Cronologia

LSE
TRES
Ivz Ust Dist
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network